Published in J Am Soc Nephrol on June 01, 1998
Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging (2012) 1.61
Pre-clinical myocardial metabolic alterations in chronic kidney disease. Cardiology (2010) 1.43
Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol (2010) 1.16
Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One (2010) 1.13
Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy. PLoS One (2011) 1.07
Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol (2009) 1.06
The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions. J Card Fail (2015) 1.06
High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy. PLoS One (2011) 0.98
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol (2007) 0.97
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. Int J Cardiol (2014) 0.93
The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. Adv Chronic Kidney Dis (2014) 0.92
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol (2013) 0.90
Low-dose growth hormone is cardioprotective in uremia. J Am Soc Nephrol (2008) 0.89
Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.88
Hemorheology and microvascular disorders. Korean Circ J (2011) 0.85
Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study. Clin J Am Soc Nephrol (2016) 0.84
Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol (2011) 0.83
Left ventricular torsion changes post kidney transplantation. J Cardiovasc Ultrasound (2013) 0.82
Novel markers of left ventricular hypertrophy in uremia. Am J Nephrol (2010) 0.80
Focal impairment in myocardial fatty acid imaging in the left anterior descending artery area, a strong predictor for cardiac death in hemodialysis patients without obstructive coronary artery disease. Eur J Nucl Med Mol Imaging (2015) 0.79
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. Clin J Am Soc Nephrol (2010) 0.79
Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol (2015) 0.78
Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int (2014) 0.78
Sudden Cardiac Death Among Hemodialysis Patients. Am J Kidney Dis (2017) 0.78
Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study. Can J Kidney Health Dis (2015) 0.78
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int (2016) 0.78
Insulin resistance and left ventricular mass in non-diabetic hemodialysis patients. Curr Ther Res Clin Exp (2012) 0.78
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens (2014) 0.77
CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction. Clin J Am Soc Nephrol (2012) 0.76
Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure. Virchows Arch (2006) 0.76
Gene expression profiling on global cDNA arrays gives hints concerning potential signal transduction pathways involved in cardiac fibrosis of renal failure. Comp Funct Genomics (2003) 0.75
Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease. J Vet Intern Med (2017) 0.75
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol (2017) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Circulating endoglin concentration is not elevated in chronic kidney disease. PLoS One (2011) 0.75
Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease. Nephron Clin Pract (2013) 0.75
Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease. PLoS One (2016) 0.75
Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease. Hypertension (2016) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
The nephrotic syndrome. N Engl J Med (1998) 3.22
Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis (1992) 3.16
Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38
Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A (1992) 2.38
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06
Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83
Endometriosis results from the dislocation of basal endometrium. Hum Reprod (2002) 1.77
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71
Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation (1981) 1.68
Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61
Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59
Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation (1989) 1.47
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41
Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41
[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40
Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39
[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Estimation of surface area and length with the orientator. J Microsc (1990) 1.38
Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study. Eur J Nucl Med (1992) 1.38
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Eur J Clin Invest (1999) 1.38
[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant (1998) 1.36
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36
Bone histology in incipient and advanced renal failure. Kidney Int (1976) 1.35
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr (1974) 1.34
Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int (1999) 1.33
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant (1992) 1.30
Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood (1993) 1.28
Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. Kidney Int (1988) 1.27
Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int (1997) 1.27
Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int (1998) 1.26
Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol (1993) 1.24
Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int (1987) 1.24
Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 1.24
The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet (2009) 1.24
Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation (1984) 1.23
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol (1991) 1.23
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. Clin Nephrol (1980) 1.22
Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol (1993) 1.22
Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med (1979) 1.21
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20
Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet (1991) 1.20
The neuropathology of heroin abuse. Forensic Sci Int (2000) 1.19
Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant (1998) 1.19
Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int (1973) 1.18
Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol (1988) 1.17
Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant (1989) 1.17
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol (1994) 1.17
Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol (1983) 1.16
1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int (1989) 1.16
Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q J Med (1970) 1.15
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia (2003) 1.14
Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int (1999) 1.14
Lack of expression of differentiation in mouse teratoma-fibroblast somatic cell hybrids. Exp Cell Res (1973) 1.14
The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol (1997) 1.13
Reduced capillary density in the myocardium of uremic rats--a stereological study. Kidney Int (1992) 1.12
Beta blockers in the management of chronic kidney disease. Kidney Int (2006) 1.11
Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update (1999) 1.11
Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int (1987) 1.11
Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1993) 1.11
No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest (1997) 1.10
The renal risks of smoking. Kidney Int (1997) 1.10
Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant (1989) 1.10
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol (1996) 1.10
Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int (1995) 1.09
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol (2000) 1.09